GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Gross-Profit-to-Asset %

Surgical Innovations Group (LSE:SUN) Gross-Profit-to-Asset % : 21.37% (As of Dec. 2023)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Surgical Innovations Group's annualized Gross Profit for the quarter that ended in Dec. 2023 was £3.17 Mil. Surgical Innovations Group's average Total Assets over the quarter that ended in Dec. 2023 was £14.83 Mil. Therefore, Surgical Innovations Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 21.37%.


Surgical Innovations Group Gross-Profit-to-Asset % Historical Data

The historical data trend for Surgical Innovations Group's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Gross-Profit-to-Asset % Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.66 7.79 19.53 25.05 23.05

Surgical Innovations Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.40 23.77 26.10 24.11 21.37

Competitive Comparison of Surgical Innovations Group's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Surgical Innovations Group's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's Gross-Profit-to-Asset % falls into.



Surgical Innovations Group Gross-Profit-to-Asset % Calculation

Surgical Innovations Group's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=3.448/( (15.595+14.32)/ 2 )
=3.448/14.9575
=23.05 %

Surgical Innovations Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=3.168/( (15.33+14.32)/ 2 )
=3.168/14.825
=21.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Surgical Innovations Group Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group (LSE:SUN) Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.